SCHEMBL5797474

SCHEMBL5797474

CN(C)c1c(C(=O)O)nnn1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
GAA P10253 1/20 0.42
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
USP2 O75604 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
HPGD P15428 2/20 0.39
AKR1C3 P42330 1/20 0.39
MAPT P10636 2/20 0.38
TACR1 P25103 5/20 0.38
CYP2D6 P10635 2/20 0.37
TSHR P16473 2/20 0.37
PTGER4 P35408 1/20 0.37
PTGES O14684 1/20 0.37
CYP2C9 P11712 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4639498 0.83 ALDH1A1 (0.44) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL6071885 0.82 ALDH1A1 (0.45) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL5797576 0.81 HPGD (0.62) ALDH1A1GAATP53SMN1; SMN2CYP1A2
SCHEMBL4637929 0.81 HPGD (0.45) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL5797506 0.80 AKR1C3 (0.45) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL5797411 0.80 CYP2C9 (0.42) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL4705941 0.77 TP53 (0.50) ALDH1A1GAATP53SMN1; SMN2CYP1A2
SCHEMBL5796504 0.77 ALDH1A1 (0.44) ALDH1A1GAATP53SMN1; SMN2USP2
SCHEMBL4638473 0.77 ALDH1A1 (0.65) ALDH1A1GAASMN1; SMN2HPGDAKR1C3
SCHEMBL5795912 0.76 CYP2D6 (0.39) ALDH1A1GAATP53SMN1; SMN2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1646502-A Triazole derivatives as tachykinin receptor antagonists LILLY CO ELI (US) 2005-07-27 CN claimed
EP-1638944-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-03-29 EP disclosed
WO-2005000821-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-01-06 WO disclosed